Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46


Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ.

Cell Stem Cell. 2010 Nov 5;7(5):618-30. doi: 10.1016/j.stem.2010.08.012. Epub 2010 Sep 30.


Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).

Singh VK, Kumar N, Kalsan M, Saini A, Chandra R.

J Stem Cells. 2015;10(1):43-62. Review.


Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.

Rony IK, Baten A, Bloomfield JA, Islam ME, Billah MM, Islam KD.

Cell Prolif. 2015 Apr;48(2):140-56. doi: 10.1111/cpr.12162. Epub 2015 Jan 29. Review.


Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.

Ebrahimi B.

Tissue Cell. 2016 Oct;48(5):475-87. doi: 10.1016/j.tice.2016.07.005. Epub 2016 Jul 26. Review.


Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.

Li R, Bai Y, Liu T, Wang X, Wu Q.

Protein Cell. 2013 Jun;4(6):415-24. doi: 10.1007/s13238-013-2089-y. Epub 2013 May 20. Review.


Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.

Kwon D, Ji M, Lee S, Seo KW, Kang KS.

Stem Cell Rev. 2017 Feb;13(1):24-34. doi: 10.1007/s12015-016-9697-x. Review.


Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells.

Lin YC, Murayama Y, Hashimoto K, Nakamura Y, Lin CS, Yokoyama KK, Saito S.

Stem Cell Res Ther. 2014;5(2):58. Review.


Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.

Hu C, Li L.

Regen Med. 2016 Jan;11(1):105-32. doi: 10.2217/rme.15.79. Epub 2015 Dec 18. Review.


Cellular reprogramming: a small molecule perspective.

Nie B, Wang H, Laurent T, Ding S.

Curr Opin Cell Biol. 2012 Dec;24(6):784-92. doi: 10.1016/ Epub 2012 Sep 7. Review.


Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.

Skalova S, Svadlakova T, Shaikh Qureshi WM, Dev K, Mokry J.

Int J Mol Sci. 2015 Feb 13;16(2):4043-67. doi: 10.3390/ijms16024043. Review.


Induced pluripotency for translational research.

Wu M, Chen G, Hu B.

Genomics Proteomics Bioinformatics. 2013 Oct;11(5):288-93. doi: 10.1016/j.gpb.2013.08.001. Epub 2013 Sep 19. Review.


RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

Bernal JA.

J Cardiovasc Transl Res. 2013 Dec;6(6):956-68. doi: 10.1007/s12265-013-9494-8. Epub 2013 Jul 13. Review.


Proteins reprogramming: present and future.

Yang Y, Liu B, Dong J, Zhang L, Pang M, Rong L.

ScientificWorldJournal. 2012;2012:453185. doi: 10.1100/2012/453185. Epub 2012 Nov 22. Review.


Understanding the roadmaps to induced pluripotency.

Liu K, Song Y, Yu H, Zhao T.

Cell Death Dis. 2014 May 15;5:e1232. doi: 10.1038/cddis.2014.205. Review.


Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.

Gomes KM, Costa IC, Santos JF, Dourado PM, Forni MF, Ferreira JC.

Rev Assoc Med Bras (1992). 2017 Feb;63(2):180-189. doi: 10.1590/1806-9282.63.02.180. Review.


Present and future challenges of induced pluripotent stem cells.

Ohnuki M, Takahashi K.

Philos Trans R Soc Lond B Biol Sci. 2015 Oct 19;370(1680):20140367. doi: 10.1098/rstb.2014.0367. Review.


Mechanistic insights into reprogramming to induced pluripotency.

Ho R, Chronis C, Plath K.

J Cell Physiol. 2011 Apr;226(4):868-78. doi: 10.1002/jcp.22450. Review.


Progress in the reprogramming of somatic cells.

Ma T, Xie M, Laurent T, Ding S.

Circ Res. 2013 Feb 1;112(3):562-74. doi: 10.1161/CIRCRESAHA.111.249235. Review.


Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion.

Velasco I, Salazar P, Giorgetti A, Ramos-Mejía V, Castaño J, Romero-Moya D, Menendez P.

Stem Cells. 2014 Nov;32(11):2811-7. doi: 10.1002/stem.1782. Review.


Switching cell fate, ncRNAs coming to play.

Guan D, Zhang W, Zhang W, Liu GH, Belmonte JC.

Cell Death Dis. 2013 Jan 17;4:e464. doi: 10.1038/cddis.2012.196. Review.

Supplemental Content

Support Center